Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor

Previous studies from our laboratory have shown that the 5-HT2C serotonin receptor can be rendered constitutively active by changing amino acid 312 (third intracellular loop) from serine to lysine (S312K). In the present study, detailed radioligand binding analyses were performed to characterize the constitutively activated state of S312K mutant receptors. All agonists tested displayed high affinity for both [3H]5-HT and [3H]mesulergine binding to S312K receptors, but displayed low affinity for [3H]mesulergine binding to native 5-HT2C receptors. [3H]5-HT labeled the same total number of S312K binding sites as [3H]mesulergine. 5-HT2C antagonists inhibited S312K basal inositol phosphate production. These results suggest that S312K receptors mimic the active conformation of native 5-HT2C receptors and provide a good model system for evaluating drugs for inverse agonist activity. Also, S312K receptors may represent a new system for screening 5-HT2C agonist activity by comparing [3H]mesulergine binding to native and S312K mutant receptors.